Alerts will be sent to your verified email
Verify Email
SHUKRAPHAR
|
Shukra Pharma
|
Kwality Pharma
|
Windlas Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 25.27 % | 10.64 % |
|
5yr average Equity Multiplier
|
2.02 | 1.96 | 1.39 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.05 | 1.07 |
|
5yr Avg Net Profit Margin
|
13.41 % | 11.66 % | 7.49 % |
|
Price to Book
|
24.95 | 5.43 | 2.87 |
|
P/E
|
56.31 | 27.85 | 22.98 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | 55.02 Days | -12.87 Days |
|
Inventory Days
|
40.87 Days | 67.04 Days | 39.91 Days |
|
Days Receivable
|
186.38 Days | 132.46 Days | 72.81 Days |
|
Days Payable
|
342.97 Days | 126.93 Days | 93.99 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 16.13 | 42.87 |
|
5yr Avg ROCE
|
14.63 % | 34.73 % | 16.39 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 23.23 % | 12.11 % |
|
5 yr average Debt to Equity
|
0.23 | 0.46 | 0.05 |
|
5yr CAGR Net Profit
|
119.04 % | 21.34 % | 30.97 % |
|
5yr Average Return on Assets
|
8.68 % | 12.96 % | 7.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 54.83 % | 61.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.79 % | 0.38 % | 1.24 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -4.76 % |
|
Shukra Pharma
|
Kwality Pharma
|
Windlas Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|